Type 1 Diabetes Screening and Early Detection in Children

HEALTH CONDITIONS

Should My Child Be Screened for Type 1 Diabetes?  

Active child on a soccer field with a continuous glucose monitor on the arm, representing Type 1 diabetes awareness, screening, and early detection in children.

Many parents are aware of the common signs of type 1 diabetes such as excessive thirst, frequent urination, weight loss, and fatigue. What many don’t realize is that long before those symptoms start, changes may already be happening in a child’s body. 

For years, type 1 diabetes, which is an autoimmune condition, was typically diagnosed only after symptoms appeared. That meant that in some cases, children became seriously ill before anyone knew what was happening. Today, researchers and clinicians understand much more about how it develops, creating opportunities to identify risk earlier than ever before. 

If you’ve only recently heard about type 1 diabetes screening, you’re not alone. For parents who are wondering what it involves, whether it’s something to consider, and what happens if a screening result is positive, here’s what you need to know. 

Can type 1 diabetes be detected before symptoms start? 

Type 1 diabetes, which is an autoimmune condition, doesn’t develop overnight. Researchers now understand that the condition progresses through stages before symptoms are reported. During these early stages, the immune system begins attacking the insulin-producing cells in the pancreas. As this process unfolds, the body produces markers called autoantibodies that screening can detect. These autoantibodies may be present for months or even years before a child has any symptoms. 

Early detection doesn’t mean type 1 diabetes can always be prevented. But it can give families information they didn’t previously have, allowing them to: 

  • Monitor their child’s health more closely. 
  • Learn what symptoms to watch for. 
  • Work with specialists when appropriate. 
  • Reduce the likelihood of a medical emergency at diagnosis. 
  • Participate in clinical research trials or consider medications that may potentially delay onset of type 1 diabetes

For many families, having time to prepare can make a meaningful difference.  

Pediatric healthcare provider demonstrates a diabetes testing device while discussing Type 1 diabetes screening with a child and caregiver.

Who might consider screening? 

Historically, discussions about type 1 diabetes screening have focused on children who have a family history of the condition. However, one of the biggest shifts in recent years has been the growing understanding that family history doesn’t tell the whole story. In fact, most children diagnosed with type 1 diabetes do not have a close family member with it. 

For many families, this comes as a surprise. If type 1 diabetes isn’t part of your family’s medical history, screening for type 1 diabetes may never have been something you considered — or even knew was available. That’s also one reason awareness around type 1 diabetes screening has grown. Parents who don’t have diabetes in their family may not realize that screening is something they can discuss with their child’s pediatrician. 

That doesn’t mean every child should be screened or that screening is right for every family. But it does mean the conversation is beginning to extend beyond families already known to be at higher risk. 

Why haven’t more parents heard about screening? 

If this is the first time you’ve heard about screening for type 1 diabetes, there may be a reason. For many years, type 1 diabetes was primarily diagnosed after symptoms appeared. Screening for early-stage disease was largely limited to research settings and certain high-risk populations. 

As researchers have learned more about predicting type 1 diabetes — and as treatments and monitoring strategies have evolved — interest in early detection has increased. Screening programs are beginning to expand into clinical settings, and more healthcare providers are discussing early risk identification. That means more parents may start hearing about screening as part of routine conversations about children’s health. 

Child and caregiver review a screening-related medical device with a healthcare provider during a preventive care appointment.

What does screening involve? 

Screening is simple: a small blood sample, often from a finger stick, is tested for autoantibodies linked to type 1 diabetes. Depending on the screening program, it may be offered through: 

What do the results mean? 

One of the biggest concerns parents have is: What happens if a type 1 diabetes test result comes back positive? 

If results are negative 

A negative result means no diabetes-related autoantibodies were detected at the time of screening. 

For many families, that can provide reassurance. However, a negative result doesn’t completely eliminate future risk. Your child’s healthcare provider can help determine whether additional screening is appropriate based on individual circumstances. 

If results are positive for autoantibodies 

A positive screening result indicates one or more diabetes-related autoantibodies were detected, but follow-up testing is needed to confirm the findings. 

Screening results can mean different things depending on how many autoantibodies are found and confirmed. One confirmed autoantibody indicates an increased risk of developing type 1 diabetes, while two or more indicate an early stage of the condition, even if your child feels healthy and has no symptoms.  

What happens after a positive screening? 

For many parents, the thought of a positive result can feel overwhelming. But a positive screening result isn’t the end of the story, it’s often the beginning of a more informed care plan. 

Depending on your child’s situation, next steps may include: 

  • Referral to a pediatric endocrinologist. 
  • Additional testing or monitoring. 
  • Education about symptoms and disease progression. 
  • Ongoing follow-up visits. 

One of the biggest benefits of early identification is that children who are monitored are often diagnosed before they become critically ill. Families can also learn about research opportunities and clinical trials as well as treatments that may help delay progression. 

In other words, screening isn’t simply about finding risk. It’s about the opportunity to prepare, plan, and respond earlier. 

Child and caregiver meet with a pediatric healthcare provider to discuss Type 1 diabetes screening, risk factors, and early detection options.

What does the decision to screen mean for you?  

Type 1 diabetes in children can still feel sudden for many families, no matter how it’s discovered. A child may appear healthy one day and receive a diagnosis soon after. What’s different about screening is that, in some cases, the condition can be identified long before signs and symptoms appear. That knowledge opens door to conversations that didn’t exist a generation ago. 

At the same time, screening isn’t required, and it may not be the right choice for every family. 

Some parents may decide they want additional information as early as possible. Others may prefer not to pursue screening unless there’s a known risk factor, especially a parent or sibling with type 1 diabetes. Both perspectives are understandable, and the decision is ultimately personal, made in partnership with a child’s healthcare providers.  

Additional Resources and Next Steps 

If you’re considering type 1 diabetes screening for your child, their pediatrician can help you understand the potential benefits, limitations, and available options. Breakthrough T1D® (formerly JDRF) also offers a decision tool to help families make informed choices about screening. 

If additional evaluation or monitoring is needed, a pediatric endocrinologist can help guide next steps.  


Families in Delaware and surrounding communities interested in learning more about Type 1 diabetes screening through the Breakthrough T1D Early Detection Pilot Program at Nemours Children’s Hospital, Delaware can contact Patrick Hanley, MD at Patrick.Hanley@nemours.org.

Patrick Hanley, MD

Patrick Hanley, MD, is Interim Division Chief of Pediatric Endocrinology at Nemours Children's Hospital, Delaware. He specializes in caring for children with diabetes and other endocrine disorders and is involved in clinical research focused on Type 1 diabetes. His work aims to improve early detection, treatment, and outcomes for children and families affected by diabetes.

Check out more about this provider